Kisspeptin-10 — questions, answered plainly.

Kisspeptin-10 (KP-10) is a 10-amino-acid C-terminal fragment of the KISS1 gene product. It activates the KISS1 receptor (also called GPR54). It is studied across cell-based signalling assays, knockout-mouse models, and human reproductive-endocrinology pharmacology contexts.

KISS1R (also named GPR54) is a G-protein coupled receptor that responds to kisspeptins. Activation of KISS1R triggers GnRH (gonadotropin-releasing hormone) neurons in the hypothalamus, placing kisspeptin signalling at a critical node in reproductive endocrinology.

Yes — kisspeptin pharmacology has been studied in human reproductive-endocrinology research, generally with short controlled-pharmacology designs in volunteers. Long-term and chronic-administration data in humans are limited.

Newer studies, including Li et al. 2024 and Son et al. 2018, have associated KP-10 / GPR54 signalling with osteoclast and osteoblast biology in cell and knockout-mouse models. These are early-stage observations and have not been confirmed in human trials.

Kisspeptin neurons sit upstream of GnRH release and are central to puberty initiation and reproductive-axis regulation. KP-10 has been used in human pharmacology studies as a probe of the reproductive axis.

Reproductive-endocrinology human studies typically use short controlled pharmacology designs; chronic-administration data are limited. Bone-biology findings are early-stage and have not been confirmed in human trials.